Molecular analysis for therapy choice: NCI MATCH

Semin Oncol. 2014 Jun;41(3):297-9. doi: 10.1053/j.seminoncol.2014.05.002. Epub 2014 May 22.

Authors

Barbara A Conley¹, James H Doroshow²

Affiliations

¹ Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
² Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD. Electronic address: [email protected].

PMID: 25023344
DOI: 10.1053/j.seminoncol.2014.05.002

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents / therapeutic use*
Biomarkers, Tumor / analysis*
Decision Making*
Humans
Molecular Targeted Therapy*
Neoplasms / drug therapy*
Neoplasms / genetics
Neoplasms / metabolism

Substances

Antineoplastic Agents
Biomarkers, Tumor